Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 25 | 2023 | 20822 | 1.150 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2021 | 255 | 0.810 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2018 | 1205 | 0.740 |
Why?
|
Fertility | 2 | 2021 | 781 | 0.570 |
Why?
|
Ovariectomy | 1 | 2018 | 661 | 0.530 |
Why?
|
Uterine Hemorrhage | 1 | 2015 | 255 | 0.470 |
Why?
|
Ovary | 1 | 2018 | 981 | 0.450 |
Why?
|
Amenorrhea | 1 | 2015 | 485 | 0.410 |
Why?
|
Organs at Risk | 1 | 2012 | 346 | 0.370 |
Why?
|
Radiation Injuries | 2 | 2013 | 1180 | 0.320 |
Why?
|
Receptor, erbB-2 | 5 | 2023 | 2416 | 0.320 |
Why?
|
BRCA2 Protein | 3 | 2023 | 794 | 0.310 |
Why?
|
BRCA1 Protein | 4 | 2023 | 1149 | 0.310 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2013 | 806 | 0.290 |
Why?
|
Endometrial Neoplasms | 2 | 2013 | 1353 | 0.280 |
Why?
|
Preoperative Care | 1 | 2015 | 2250 | 0.280 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 814 | 0.280 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9239 | 0.240 |
Why?
|
Neoadjuvant Therapy | 4 | 2023 | 2728 | 0.220 |
Why?
|
Receptors, Estrogen | 3 | 2020 | 2187 | 0.210 |
Why?
|
Lymphatic Metastasis | 2 | 2021 | 2924 | 0.210 |
Why?
|
Pregnancy Rate | 2 | 2020 | 643 | 0.190 |
Why?
|
Quality of Life | 3 | 2021 | 12804 | 0.190 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2012 | 2020 | 0.180 |
Why?
|
Live Birth | 2 | 2020 | 512 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11524 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5442 | 0.150 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 577 | 0.150 |
Why?
|
Receptors, Progesterone | 1 | 2021 | 1097 | 0.140 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2022 | 3479 | 0.140 |
Why?
|
Age Factors | 5 | 2021 | 18370 | 0.140 |
Why?
|
Female | 28 | 2023 | 380194 | 0.140 |
Why?
|
Prospective Studies | 10 | 2023 | 53288 | 0.140 |
Why?
|
Germ-Line Mutation | 2 | 2023 | 1788 | 0.140 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2022 | 1524 | 0.130 |
Why?
|
Mastectomy | 2 | 2020 | 1793 | 0.130 |
Why?
|
Goserelin | 1 | 2015 | 129 | 0.130 |
Why?
|
Confidence Intervals | 1 | 2020 | 2971 | 0.130 |
Why?
|
Age Distribution | 1 | 2020 | 2902 | 0.120 |
Why?
|
Adult | 19 | 2022 | 214055 | 0.120 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 135 | 0.120 |
Why?
|
Leuprolide | 1 | 2015 | 321 | 0.120 |
Why?
|
Pregnancy Outcome | 2 | 2021 | 2795 | 0.120 |
Why?
|
Tamoxifen | 1 | 2018 | 981 | 0.110 |
Why?
|
Young Adult | 7 | 2022 | 56430 | 0.110 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1101 | 0.110 |
Why?
|
Lymphatic Irradiation | 1 | 2012 | 103 | 0.110 |
Why?
|
Humans | 29 | 2023 | 744343 | 0.100 |
Why?
|
Adaptation, Psychological | 1 | 2022 | 2576 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1405 | 0.100 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2012 | 876 | 0.100 |
Why?
|
Anxiety | 2 | 2022 | 4297 | 0.090 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2012 | 358 | 0.090 |
Why?
|
Adolescent | 6 | 2022 | 85781 | 0.090 |
Why?
|
Duodenum | 1 | 2012 | 483 | 0.090 |
Why?
|
Pregnancy | 5 | 2021 | 29144 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3474 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9849 | 0.080 |
Why?
|
Genetic Testing | 1 | 2021 | 3444 | 0.080 |
Why?
|
Germ Cells | 2 | 2022 | 631 | 0.080 |
Why?
|
Survivors | 3 | 2022 | 2291 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4851 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1956 | 0.070 |
Why?
|
Cisplatin | 1 | 2012 | 1662 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2022 | 8642 | 0.070 |
Why?
|
Intestine, Small | 1 | 2012 | 1241 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2021 | 77449 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12245 | 0.070 |
Why?
|
Aorta | 1 | 2012 | 2061 | 0.060 |
Why?
|
Central Nervous System Neoplasms | 1 | 2013 | 895 | 0.060 |
Why?
|
Colon | 1 | 2012 | 1772 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6365 | 0.060 |
Why?
|
Time Factors | 3 | 2020 | 40075 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9438 | 0.060 |
Why?
|
Decision Making | 1 | 2017 | 3887 | 0.060 |
Why?
|
Prognosis | 2 | 2021 | 29063 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2020 | 63114 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57776 | 0.050 |
Why?
|
Phthalazines | 1 | 2023 | 363 | 0.050 |
Why?
|
Cohort Studies | 2 | 2020 | 40561 | 0.050 |
Why?
|
Medicare | 1 | 2018 | 6566 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.040 |
Why?
|
Aged | 5 | 2022 | 163280 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13695 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1000 | 0.040 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2021 | 482 | 0.040 |
Why?
|
Mutation | 1 | 2021 | 29786 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6895 | 0.040 |
Why?
|
Paclitaxel | 1 | 2023 | 1708 | 0.030 |
Why?
|
Body Image | 1 | 2020 | 610 | 0.030 |
Why?
|
Life Expectancy | 1 | 2022 | 1184 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2020 | 956 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 707 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1049 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1531 | 0.030 |
Why?
|
Child | 3 | 2021 | 77709 | 0.030 |
Why?
|
Fear | 1 | 2021 | 1440 | 0.030 |
Why?
|
Middle Aged | 5 | 2022 | 213383 | 0.030 |
Why?
|
Social Support | 1 | 2022 | 2118 | 0.030 |
Why?
|
Anorexia | 1 | 2013 | 161 | 0.030 |
Why?
|
Weight Gain | 1 | 2022 | 2292 | 0.030 |
Why?
|
Body Weight | 1 | 2022 | 4669 | 0.020 |
Why?
|
Mammography | 1 | 2022 | 2476 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2622 | 0.020 |
Why?
|
Nausea | 1 | 2013 | 673 | 0.020 |
Why?
|
Vomiting | 1 | 2013 | 636 | 0.020 |
Why?
|
United States | 1 | 2018 | 69872 | 0.020 |
Why?
|
Alopecia | 1 | 2013 | 382 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3064 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11031 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2013 | 2879 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2861 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5720 | 0.020 |
Why?
|
Headache | 1 | 2013 | 1226 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2013 | 1004 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 72290 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6538 | 0.010 |
Why?
|
Depression | 1 | 2020 | 7766 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23338 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6234 | 0.010 |
Why?
|
Infant | 1 | 2013 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 41006 | 0.010 |
Why?
|
Male | 1 | 2013 | 350118 | 0.000 |
Why?
|
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_